Dan Reinstein
Corneal and Contact Management · LondonNPI 1770900995
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,950,900 of the $2,636,510 with a category attached, or 74.0%. Carl Zeiss Meditec AG accounts for 85.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $742,940 and has fallen 100.0% since, to $203 in 2025.
Across 191 payments — averaging $13,804 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec AG$2.2M
- Carl Zeiss Meditec, Inc.$389K
- Carl Zeiss Meditec USA, Inc.$381
- Pfizer$40
What the payments were for
- Consulting fees$1,950,90074%
- Speaking & faculty fees$676,08226%
- Travel & lodging$1,7680%
- Food & beverage$2,0760%
- Education$5,6840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec AG | 138 | $2,247,263 |
| Carl Zeiss Meditec, Inc. | 48 | $388,826 |
| Carl Zeiss Meditec USA, Inc. | 4 | $381 |
| Pfizer | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VisuMax$2,389,112
- MEL 90$1,021,582
- PRESBYOND$280,857
- ATLAS 500$273,569
- FORUM$235,642
- MEL 80$99,911
- IOLMaster 700$28,495
- EQ Workplace$22,383
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.